TA
ELV icon

Thor Advisors’s Elevance Health ELV Stock Holding History

Thor Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$69K Buy
+239
New +$69.1K 0.86% 35

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Thor Advisors's ELV Position: Q1 2019 in Review

Thor Advisors opened a new position in Elevance Health (ELV) in Q1 2019: 239 shares worth $69K. The stake represents 0.86% of the portfolio and ranks #35 among its holdings.

1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • Thor Advisors held 239 shares of Elevance Health worth $69K as of Q1 2019.
  • Elevance Health was a new Thor Advisors position in Q1 2019.
  • Elevance Health made up 0.86% of Thor Advisors's portfolio in Q1 2019, its #35 holding.
  • 1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Thor Advisors's 13F filing for Q1 2019, filed 12 Jun 2019.